Figure 1 2 MASLDs pathophysiology and current treatment MASLD is characterized by an abnormal accumulation of lipids in hepatocytes, commonly occurring in the context of obesity, insulin resistance, and T2DM-key features of metabolic syndrome that substantially affect patient quality of life and long-term prognosis (1)
PQQ helps build the "power plants" (mitochondria), and glutathione protects those power plants from the "smoke" (oxidative stress) they produce
Cardiometabolic Imbalance & Glutathione Insufficiency Endothelial oxidative injury intersects with metabolic tissues, compounding insulin resistance, dyslipidemia, and systemic inflammation
Diabetes Care 39(6):884892 Horowitz M, Flint A, Jones KL, Hindsberger C, Rasmussen MF, Kapitza C et al (2012) Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes
Topics that typically come up include baseline metabolic status, kidney function, gastrointestinal history, how you have tolerated prior medications, and the FDA-approved indication the prescription is written for
